To determine the safety and efficacy of switching the treatment of HD patients with chorea from with tetrabenazine to deutetrabenazine, the HD Study Group and the Alternatives for Reducing Chorea in HD Investigators began an ongoing, open-label, single-arm study in 37 HD patients at 13 sites in the US and Australia on December 21, 2013.
Bloggers, Unite! - bloggersunite.netBloggers, Unite! - bloggersunite.net - The News and Times Blog - AI News Briefs - Audio Posts